Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Additional Paid-In Capital : ¥0.0 Mil(As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Inner Mongolia Grand Pharmaceutical Co Additional Paid-In Capital?

Inner Mongolia Grand Pharmaceutical Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0.0 Mil) to Dec. 2024 (¥1,186,443.8 Mil) but then stayed the same from Dec. 2024 (¥1,186,443.8 Mil) to Mar. 2025 (¥0.0 Mil).

Inner Mongolia Grand Pharmaceutical Co's annual additional paid-in capital declined from Dec. 2022 (¥123.5 Mil) to Dec. 2023 (¥120.4 Mil) but then increased from Dec. 2023 (¥120.4 Mil) to Dec. 2024 (¥1,186,443.8 Mil).

Inner Mongolia Grand Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Inner Mongolia Grand Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inner Mongolia Grand Pharmaceutical Co Additional Paid-In Capital Chart

Inner Mongolia Grand Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

227.34

238.10

123.48

120.44

1,186,443.78

Inner Mongolia Grand Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial															-	118.64	-	1,186,443.78	-

Inner Mongolia Grand Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Inner Mongolia Grand Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Grand Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Inner Mongolia Grand Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inner Mongolia Grand Pharmaceutical Co Ltd (BJSE:836433) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

Wuwei Road, 2nd Floor, Administration Building, Ruyi Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010010

Website

http://www.nmdt.com.cn

Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production and sales of special specialty medicines and general health products. The company's main business is the research and development and production of Chinese patent medicines (including ethnic medicines) and chemical preparations and sales.

Inner Mongolia Grand Pharmaceutical Co Headlines

No Headlines